


Allegria Therapeutics
Biotechnology Research • Basel, Basel, Switzerland • 1-10 Employees
Company overview
| Headquarters | Basel, Basel, Switzerland |
| Website | |
| NAICS | 541714 |
| Keywords | Allergy, Inflammatory Disease, Mast Cell-Targeted Therapeutics |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contact at Allegria Therapeutics
Maria Van Dongen
Chief Executive Officer & Co-founder
About Allegria Therapeutics
Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that directly and selectively modulate mast cells, Allegria aims to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com
Allegria Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | $3,500,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Allegria Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Allegria Therapeutics Tech Stack
Discover the technologies and tools that power Allegria Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
Databases
Miscellaneous
Programming languages
Blogs
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
Miscellaneous
Performance
Frequently asked questions
4.8
40,000 users



